Karls, Shawn
Gold, Richard
Kravets, Sasha
Wang, Yating
Cheng, SuChun
Perez, Kimberly
Chan, Jennifer
Jacene, Heather http://orcid.org/0000-0001-7167-078X
Article History
Received: 15 February 2021
Accepted: 8 June 2021
First Online: 19 June 2021
Declarations
:
: Dr. Heather Jacene discloses Advanced Accelerator Applications—consulting fees, American Roentgen Ray Society—stipend, Australian and New Zealand Urogenital and Prostate Cancer Clinical Trial Group—honoraria, Cambridge University Press—royalties, Janssen—honoraria, Siemens Healthcare, GTx, Inc, Blue Earth Diagnostics, Inc—research support to institution. Dr. Jennifer Chan discloses—consulting for Advanced Accelerator Applications, Lexicon, Ipsen and Stock Ownership: Merck. The rest of the authors have no conflicts of interest to disclose.